STAAR Surgical Co

13 aug. 2026, 20:02 UTC

STAAR Surgical shares are lower after UBS cut its price target to $19.00, despite reporting strong second-quarter sales of $93.5 million.

12 aug. 2026, 23:56 UTC

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

11 aug. 2026, 20:01 UTC

STAAR Surgical Co shares are lower today, reflecting broader market declines amid rising oil prices and inflation concerns ahead of U.S. inflation reports.

10 aug. 2026, 20:02 UTC

Broadwood has acquired over 1 million additional shares of STAAR Surgical, reflecting its long-term strategy, as the stock trades higher since Friday's close.

7 aug. 2026, 22:56 UTC

Shares of STAAR Surgical Co. are trading higher in after-market hours, continuing a positive trend amid a supportive market backdrop following a decline in the unemployment rate.

6 aug. 2026, 20:03 UTC

STAAR Surgical Co. shares are higher today, reflecting gains since Wednesday's close, though the stock remains below its 20-day moving average.

5 aug. 2026, 20:02 UTC

STAAR Surgical shares are lower today, continuing a decline since Tuesday's close amid broader market volatility and external factors not directly impacting the company.

4 aug. 2026, 19:51 UTC

STAAR Surgical Co shares are lower as Health Care Supplies sub-sector performance weighs on the stock. No specific news was identified for the decline.

3 aug. 2026, 20:03 UTC

No specific news for STAAR Surgical as shares trade near unchanged. The broader market sees gains amid strong buying interest in technology stocks.

31 iul. 2026, 19:52 UTC

STAAR Surgical Co shares are lower amid weakness in the Health Care Supplies sub-sector. The stock has seen modest declines since Thursday's close.

30 iul. 2026, 19:29 UTC

STAAR Surgical Co. shares are lower today, reflecting a decline since Wednesday amid broader market volatility and rising Treasury yields.

29 iul. 2026, 22:11 UTC

STAAR Surgical Co shares are lower in after-market hours amid significant declines in the Health Care Supplies sub-sector, with no specific news identified.

28 iul. 2026, 18:56 UTC

STAAR Surgical Co shares declined after UBS initiated coverage with a Sell rating and set a price target of $20.00, closing at $22.95.

27 iul. 2026, 19:07 UTC

STAAR Surgical Co. shares are trading lower, continuing a recent downward trend amid broader market sentiment affected by declining crude oil prices.

22 iul. 2026, 18:11 UTC

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21 iul. 2026, 16:56 UTC

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20 iul. 2026, 20:01 UTC

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.